{"data":[{"accessionNo":"0000902664-26-003461","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals, Inc.","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Avoro Capital Advisors LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":13823383,"percentOfClass":9.64,"filedAt":"2026-08-14"},{"accessionNo":"0000902664-26-003461","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals, Inc.","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Behzad Aghazadeh","reportingCik":null,"personType":"HC,IN","sharesOwned":13823383,"percentOfClass":9.64,"filedAt":"2026-08-14"},{"accessionNo":"0002100121-26-000891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals Inc","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":6384903,"percentOfClass":4.53,"filedAt":"2026-07-31"},{"accessionNo":"0002012383-26-002186","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000879407","issuerName":"ARROWHEAD PHARMACEUTICALS INC","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":14232545,"percentOfClass":10.1,"filedAt":"2026-07-27"},{"accessionNo":"0000315066-26-001120","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000879407","issuerName":"ARROWHEAD PHARMACEUTICALS INC","ticker":"ARWR","cusip":"04280A100","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":7349106.75,"percentOfClass":5.2,"filedAt":"2026-05-06"},{"accessionNo":"0000315066-26-001120","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000879407","issuerName":"ARROWHEAD PHARMACEUTICALS INC","ticker":"ARWR","cusip":"04280A100","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":7349106.75,"percentOfClass":5.2,"filedAt":"2026-05-06"},{"accessionNo":"0002100119-26-000162","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals Inc","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":7081293,"percentOfClass":5.05,"filedAt":"2026-04-29"},{"accessionNo":"0002100121-26-000087","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals Inc","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":7269957,"percentOfClass":5.19,"filedAt":"2026-04-28"},{"accessionNo":"0002012383-26-001435","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000879407","issuerName":"ARROWHEAD PHARMACEUTICALS INC","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":17104084,"percentOfClass":12.2,"filedAt":"2026-04-24"},{"accessionNo":"0000102909-26-000629","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0000879407","issuerName":"Arrowhead Pharmaceuticals Inc","ticker":"ARWR","cusip":"04280A100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0002012383-26-000644","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000879407","issuerName":"ARROWHEAD PHARMACEUTICALS INC","ticker":"ARWR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":20323221,"percentOfClass":15,"filedAt":"2026-01-21"}],"updatedAt":"2026-10-15T11:00:29.496Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}